When the Covid-19 pandemic started, UCLH paused all trials unless they were related to Covid-19, or where treatment involved was essential for serious or life-threatening conditions.
With rates of infection and pressure on the NHS due to Covid-19 receding, we have now restarted a large proportion of our trials, after a rigorous review for each trial looking at:
- whether the different departments, such as imaging and pharmacy, have the capacity to support the trial
- whether patients need any visits to the hospital which are not for standard patient care
- whether they are compatible with UCLH-wide safety measures – as outlined on our web pages with information for patients and visitors.
This review is carried out by clinicians, managers and support services and includes patients on the panel.
Ongoing safety measures
A number of measures remain in place at UCLH to keep all patients, research participants and staff safe.
We request that all visitors still wear a face mask, keep a safe distance, and clean their hands with gel in all our buildings. This includes people who have been fully vaccinated.
Read the full UCLH advice on coming to the hospital.
